With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI ...

Long-term weight stability is recommended to improve health outcomes in individuals with type 1 diabetes. Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling ...

For the study, more than 12,000 people with type 2 diabetes who had elevated systolic blood pressure and an increased risk of cardiovascular disease were recruited. Participants were randomly ...

children. For example, CKD in babies is most likely caused by birth defects or genetic illnesses, while adult CKD is most likely caused by non-communicable diseases including diabetes and high blood ...

Intensive treatment to control systolic blood pressure (BP) to less than 120 mmHg significantly ... an increased risk of cardiovascular disease and type 2 diabetes, to receive either intensive ...

You may relieve diabetic nerve pain with medications and some forms of exercise. Managing diabetes helps with long-term relief and slows down the progression of nerve damage. Diabetes may cause ...